Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Reactions at the Benzylic Position: Halogenation01:11

Reactions at the Benzylic Position: Halogenation

3.0K
Benzylic halogenation takes place under conditions that favor radical reactions such as heat, light, or a free radical initiator like peroxide.
3.0K
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene01:15

Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene

9.5K
Chlorination and bromination are important classes of electrophilic aromatic substitutions, where benzene reacts with chlorine or bromine in the presence of a Lewis acid catalyst to give halogenated substitution products. A Lewis acid such as aluminium chloride or ferric chloride catalyzes the chlorination, and ferric bromide catalyzes the bromination reactions. During the bromination of alkenes, bromine polarizes and becomes electrophilic. However, in the bromination of benzene, the bromine...
9.5K
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

557
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
557
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

901
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
901
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

772
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
772
Ketones with Nonenolizable Aromatic Aldehydes: Claisen–Schmidt Condensation01:01

Ketones with Nonenolizable Aromatic Aldehydes: Claisen–Schmidt Condensation

3.9K
Benzaldehyde, like formaldehyde, lacks an α hydrogen and cannot enolize to form an enolate. Hence, the reaction of benzaldehyde with a ketone in the presence of an aqueous base forms a single crossed product. This reaction is referred to as Claisen–Schmidt condensation.
As the self-condensation of ketones is generally not favored in basic conditions, the self-condensed products do not form in the reaction between ketones and benzaldehyde. The general reaction of Claisen–Schmidt...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dataset on criteria for evaluating teaching quality in blended learning environments: Evidence from a Vietnamese university.

Data in brief·2026
Same author

Clinical outcomes and costs associated with viral lower respiratory tract disease hospitalisations.

BMJ open respiratory research·2026
Same author

Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III Trials.

Ophthalmology. Retina·2026
Same author

Postoperative Inflammation and Pain Management with Intracanalicular Dexamethasone Insert: Real-World Applications.

Ophthalmology and therapy·2026
Same author

Technical note: The UF/MSK pediatric mesh-based computational human phantom library: applications to organ dosimetry in computed tomography.

Physics in medicine and biology·2026
Same author

Machine Learning to Predict Outcomes and Dosing Frequency With Aflibercept for Macular Edema Following Central Retinal Vein Occlusion.

Ophthalmic surgery, lasers & imaging retina·2026

Related Experiment Video

Updated: Oct 28, 2025

A Whole Mount In Situ Hybridization Method for the Gastropod Mollusc Lymnaea stagnalis
07:33

A Whole Mount In Situ Hybridization Method for the Gastropod Mollusc Lymnaea stagnalis

Published on: March 15, 2016

9.0K

Ocular benzalkonium chloride exposure: problems and solutions.

Michael H Goldstein1, Fabiana Q Silva1, Nysha Blender1

  • 1Ocular Therapeutix, Inc, Bedford, Massachusetts, USA.

Eye (London, England)
|July 15, 2021
PubMed
Summary
This summary is machine-generated.

Benzalkonium chloride (BAK) in eye drops damages ocular surfaces, causing discomfort and vision issues. This review explores BAK

More Related Videos

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

2.3K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

921

Related Experiment Videos

Last Updated: Oct 28, 2025

A Whole Mount In Situ Hybridization Method for the Gastropod Mollusc Lymnaea stagnalis
07:33

A Whole Mount In Situ Hybridization Method for the Gastropod Mollusc Lymnaea stagnalis

Published on: March 15, 2016

9.0K
Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

2.3K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

921

Area of Science:

  • Ophthalmology
  • Toxicology
  • Drug Delivery

Background:

  • Preservatives like benzalkonium chloride (BAK) are vital for ophthalmic medication sterility but can harm the ocular surface.
  • BAK, present in ~70% of eye drops, causes cytotoxic damage to corneal and conjunctival cells, leading to ocular surface disease (OSD).
  • Adverse effects of BAK are dose-dependent and can occur with both chronic use (e.g., glaucoma therapy) and short-term exposure.

Purpose of the Study:

  • To review the cytotoxic and clinical impacts of benzalkonium chloride on the ocular surface.
  • To discuss current and novel strategies for minimizing or eliminating BAK exposure in ophthalmic treatments.

Main Methods:

  • Literature review of studies on benzalkonium chloride's effects on ocular tissues.
  • Analysis of clinical outcomes associated with BAK exposure in ophthalmic formulations.
  • Evaluation of alternative preservatives, preservative-free options, and non-pharmacological therapies.

Main Results:

  • BAK induces significant damage to ocular surface cells, manifesting as ocular surface staining, reduced tear film stability, and increased OSD symptoms.
  • Even short-term exposure to BAK can lead to adverse ocular surface changes.
  • Various strategies, including alternative preservatives and preservative-free formulations, can mitigate BAK-induced toxicity.

Conclusions:

  • Benzalkonium chloride poses a significant risk to ocular surface health, particularly with long-term use.
  • Minimizing BAK exposure through alternative formulations and therapies is crucial for managing ocular surface disease.
  • Emerging strategies offer promising solutions for preservative-free ophthalmic treatment.